Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) closed the day trading at $5.35 up 1.52% from the previous closing price of $5.27. In other words, the price has increased by $1.52 from its previous closing price. On the day, 1.35 million shares were traded. SNOA stock price reached its highest trading level at $5.35 during the session, while it also had its lowest trading level at $4.612.
Ratios:
For a better understanding of SNOA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.87 and its Current Ratio is at 2.66. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 03 ’25 when Gottfurcht Grant bought 86,111 shares for $2.70 per share.
Gottfurcht Grant bought 30,000 shares of SNOA for $80,684 on Jan 02 ’25. On Dec 31 ’24, another insider, Gottfurcht Grant, who serves as the Open Market Purchase of the company, bought 17,806 shares for $2.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNOA now has a Market Capitalization of 8791441 and an Enterprise Value of 5861468. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.59 while its Price-to-Book (P/B) ratio in mrq is 2.17. Its current Enterprise Value per Revenue stands at 0.393 whereas that against EBITDA is -1.676.
Stock Price History:
The Beta on a monthly basis for SNOA is 1.42, which has changed by 0.028846145 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, SNOA has reached a high of $6.92, while it has fallen to a 52-week low of $1.75. The 50-Day Moving Average of the stock is 62.82%, while the 200-Day Moving Average is calculated to be 82.46%.
Shares Statistics:
Over the past 3-months, SNOA traded about 1.25M shares per day on average, while over the past 10 days, SNOA traded about 7626700 shares per day. A total of 1.64M shares are outstanding, with a floating share count of 1.62M. Insiders hold about 1.30% of the company’s shares, while institutions hold 5.17% stake in the company. Shares short for SNOA as of 1753920000 were 19087 with a Short Ratio of 0.02, compared to 1751241600 on 6266. Therefore, it implies a Short% of Shares Outstanding of 19087 and a Short% of Float of 1.54.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
1 analysts predict $4.26M in revenue for the current quarter. It ranges from a high estimate of $4.26M to a low estimate of $4.26M. As of the current estimate, Sonoma Pharmaceuticals Inc’s year-ago sales were $3.58MFor the next quarter, 1 analysts are estimating revenue of $4.33M. There is a high estimate of $4.33M for the next quarter, whereas the lowest estimate is $4.33M.
Based on 1 analysts’ estimates, the company’s revenue will be $21.47M in the next fiscal year. The high estimate is $21.47M and the low estimate is $21.47M.
